Human CMV immediate‐early enhancer: a useful tool to enhance cell‐type‐specific expression from lentiviral vectors
- 19 November 2007
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 10 (1) , 21-32
Abstract
Background: Lentiviral vectors are attractive delivery tools for gene therapy, especially in terminally differentiated target cells. While restriction of gene expression to specific cell populations is of particular importance, highly efficient cell‐type‐specific gene expression after viral gene transfer so far has been hampered by low levels of transgene expression.Methods: Addressing this problem, we have integrated the human cytomegalovirus (CMV) immediate‐early enhancer into an ‘advanced’ generation lentiviral vector. Expression cassettes with the reporter gene green fluorescent protein (GFP), combined with the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) under control of a ubiquitous phosphoglycerate kinase (mouse PGK), cardiomyocyte‐ (human atrial natriuretic factor (ANF), human ventricular myosin light chain (MLC2v)), or type II alveolar epithelial cell (AT‐2)‐specific human surfactant protein C (SP‐C) promoter, were introduced. As insertion of an enhancing element can interfere with the promoter's specificity, expression levels conferred by our enhancer/promoter constructs were evaluated in target and non‐target cells.Results: Transduction of target cells with human CMV enhancer containing lentiviral vectors resulted in a multiple‐log increase in GFP expression compared to corresponding vectors lacking the human CMV enhancer. In the case of the ANF, the MLC2v, and the SP‐C promoters, tissue‐specific reporter gene expression in cardiomyocytes and in lung AT‐2 cells was maintained, as expression in non‐target cells increased only up to 7‐fold.Conclusions: The results of this study indicate that lentiviral vectors with the human CMV enhancer conferring efficient cell‐type‐specific gene expression may be useful tools for gene therapy purposes or cell tracing, e.g. to analyze stem cell differentiation in transplantation and co‐culture settings. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- No Evidence of Transdifferentiation of Human Endothelial Progenitor Cells Into Cardiomyocytes After Coculture With Neonatal Rat CardiomyocytesCirculation, 2006
- Bioluminescence Imaging of Systemic Tumor Targeting Using a Prostate-Specific Lentiviral VectorHuman Gene Therapy, 2006
- CMV enhancer/human PDGF-β promoter for neuron-specific transgene expressionGene Therapy, 2003
- In Vivo Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral VectorsHuman Gene Therapy, 2003
- High-Level Transduction and Gene Expression in Hematopoietic Repopulating Cells Using a Human Imunodeficiency Virus Type 1-Based Lentiviral Vector Containing an Internal Spleen Focus Forming Virus PromoterHuman Gene Therapy, 2002
- Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectorsGene Therapy, 2001
- A strategy for enhancing the transcriptional activity of weak cell type-specific promotersGene Therapy, 1998
- A Composite CMV-IE Enhancer/β-Actin Promoter Is Ubiquitously Expressed in Mouse Cutaneous EpitheliumExperimental Cell Research, 1998
- Lung-Specific Expression of Adenovirus E3-14.7K in Transgenic Mice Attenuates Adenoviral Vector-Mediated Lung Inflammation and Enhances Transgene ExpressionHuman Gene Therapy, 1998
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996